Materiały źródłowe

• #1 LAC | DPH – Vaccine Preventable Disease Control Program

  http://ph.lacounty.gov/ip/diseases/RSV/index.htm

  RSV vaccine can be given at the same time as other vaccines. […] Side effects from RSV vaccine are usually mild. Common side effects may include: Redness, swelling, and pain at the site of injection, Fatigue, Fever, Headache, Nausea, Diarrhea, Muscle or joint pain. […] RSV immunization effectiveness varies depending on vaccine given, previous doses, age, time, and medical history. In older adults, the RSV vaccines are at least 73-83 % effective in preventing RSV-associated emergency visits and hospitalizations in adults ages 60 years and older. In pregnant people, the maternal RSV vaccine is at least 68% effective in preventing RSV-associated hospitalizations in babies. In infants and young children, nirsevimab (Beyfortus) is at least 80-90% effective in preventing RSV-associated hospitalizations in babies.

• #2 Respiratory syncytial virus (RSV) FAQs | NCIRS

  https://ncirs.org.au/ncirs-fact-sheets-faqs-and-other-resources/respiratory-syncytial-virus-rsv-frequently-asked

  RSV is a common virus that can infect people of all ages. It can cause a range of respiratory illnesses from mild upper respiratory colds to severe lower respiratory conditions like bronchiolitis, bronchitis or pneumonia. Symptoms of RSV disease can include: runny nose, cough, fever, wheezing and difficulty breathing (including exacerbations of underlying lung disease such as asthma). […] Clinical trials for Abyrsvo have shown that use of the Abrysvo vaccine in pregnant women provided infants with good protection from severe RSV; the risk of hospitalisation from RSV infection was reduced by around 60% in infants during their first 6 months of life. […] Clinical trials for Arexvy, Abrysvo and mRESVIA (Moderna; not yet available in Australia) showed good protection against severe RSV disease in adults aged 60 years and over, with around an 80-95% reduction in the risk of severe lower respiratory tract disease in vaccinated individuals.

• #3 What to know about RSV, RSV vaccine – Mayo Clinic Health System

  https://www.mayoclinichealthsystem.org/hometown-health/featured-topic/what-parents-should-know-about-rsv

  Respiratory syncytial virus, or RSV, is a common virus that most people will get by age 2. It causes mild cold symptoms for most people, who usually recover in a week or so. […] RSV can be serious for infants and older adults, however. When severe, it can lead to bronchiolitis or pneumonia. Bronchiolitis, or inflammation of the airway, is one of the most common causes of children needing hospitalization in the winter months. […] Symptoms of RSV can be similar to other viruses, like a cold or the flu, and may include: Dry cough, Low-grade fever, Mild headache, Runny nose or congestion, Sore throat, Wheezing or difficulty breathing. […] A child with RSV may not want to eat or drink as often as usual and may be more lethargic or sleepy. […] For most children who develop RSV, home remedies can ease symptoms. RSV symptoms usually last from two to eight days, but some children might have a cough for a few weeks before fully recovering. […] Seek immediate care for a child with RSV if they develop these symptoms: Breathing that is fast, shallow or noisy, Extreme irritability, High fever, Significant decrease in eating or drinking. […] Babies and young children can become very sick quickly due to RSV.

• #4 Respiratory Syncytial Virus (RSV) | Northwestern Medicine

  https://www.nm.org/conditions-and-care-areas/respiratory-viruses/respiratory-syncytial-virus-rsv

  Symptoms of RSV can be similar to a common cold, flu or COVID-19: Fever, Cough, Congestion (runny nose), Sneezing, Wheezing, Decrease in appetite. […] For very young infants with RSV, the only symptoms may be: Irritability, Less activity, Difficulty breathing. […] Most people who get RSV have mild symptoms and recover within 1 or 2 weeks. […] Infants and older adults are at the greatest risk for severe illness and complications from RSV, including hospitalization.

• #5 RSV (Respiratory Syncytial Virus) | Vermont Department of Health

  https://www.healthvermont.gov/disease-control/immunizations/rsv-respiratory-syncytial-virus

  Most people with RSV will have only mild, cold-like symptoms, but it can be serious for infants, older adults, and people with weakened immune systems. […] RSV symptoms can be more serious in older adults because our immune systems can weaken with age. The risk is higher for older adults who also have certain medical conditions, like chronic heart or lung diseases or who are immunocompromised. […] Severe RSV can cause lung inflammation (bronchiolitis) or lung infection (pneumonia) that can make breathing difficult. […] Protection will last during your baby’s first 6 months, while they are at highest risk of severe RSV. […] Early real-world data show that nirsevimab was 80-90% effective in preventing babies from being hospitalized with RSV. It provides immediate protection against RSV and lasts at least 5 months.

• #6 Side Effects of RSV Vaccines: What’s Normal, What’s Not

  https://www.aarp.org/health/conditions-treatments/rsv-vaccine-side-effects/

  RSV typically causes cold-like symptoms, but in some cases, those symptoms can progress to a lung infection or pneumonia. RSV can worsen other health conditions such as asthma or chronic obstructive pulmonary disease (COPD). […] The CDC estimates that RSV sends 177,000 older Americans to the hospital annually; about 14,000 older adults die each year from an RSV infection. […] GBS was flagged as a rare side effect in the clinical trials testing the RSV vaccines. […] The latest data does not change recommendations, because the risk of RSV serious infection in these highly vulnerable populations is vastly greater than is the risk of Guillain-Barr.

• #7 RSV: Symptoms & Treatment | Kaiser Permanente

  https://healthy.kaiserpermanente.org/southern-california/health-wellness/rsv

  Most children will get an RSV infection with mild symptoms by the time theyre 2. […] Symptoms of RSV usually appear within 4 to 6 days after infection. Mild, cold-like symptoms typically include: Congested or runny nose, Decreased appetite, Coughing, Sneezing, Fever, Moderate wheezing. […] Severe symptoms to look out for in children include: Severe wheezing, Rapid breathing or respiratory distress, Bluish skin or fingernails, Refusal to drink liquids, Decreased number of wet diapers, Extreme tiredness. […] Some people with an RSV infection, especially older adults and infants under 6 months, may develop a lung infection, get dehydrated, or have trouble breathing. […] Older adults are at greater risk than young adults for serious complications from RSV because their immune systems are weaker.

• #8 RSV (Respiratory Syncytial Virus) Vaccine: What You Need to Know – Health Information Library | PeaceHealth

  https://www.peacehealth.org/medical-topics/id/cdc37

  RSV vaccine can prevent lower respiratory tract disease caused by respiratory syncytial virus (RSV). RSV is a common respiratory virus that usually causes mild, cold-like symptoms. […] Symptoms of RSV infection may include runny nose, decreased appetite, coughing, sneezing, fever, or wheezing. In very young infants, symptoms of RSV may also include irritability (fussiness), decreased activity, or apnea (pauses in breathing for more than 10 seconds). […] Most people recover in a week or two, but RSV can be more serious, resulting in shortness of breath and low oxygen levels. RSV can cause bronchiolitis (inflammation of the small airways in the lung) and pneumonia (infection of the lungs). RSV can also lead to worsening of other medical conditions such as asthma, chronic obstructive pulmonary disease (a chronic disease of the lungs that makes it hard to breathe), or heart failure (when the heart cannot pump enough blood and oxygen throughout the body).

• #9 Respiratory Syncytial Virus (RSV) Infection

  https://www.health.ny.gov/diseases/communicable/respiratory_syncytial_virus/

  Symptoms generally begin four to six days after exposure. Symptoms generally develop slowly over a period of several days. The contagious period is usually less than 10 days after symptoms begin, but occasionally is longer. Symptoms, particularly a cough, may persist for a few days to several weeks. […] If you or your child have symptoms consistent with RSV, or any respiratory illness, and you are concerned about severe illness, contact a health care provider right away who can help you with diagnosis, treatment, and care. While sick, stay home from school or work to prevent spreading the illness. Cover your cough/sneezes, wash your hands and avoid close contacts and clean frequently touched surfaces.

• #10 RSV (Respiratory Syncytial Virus) Vaccine: What You Need to Know – Health Information Library | PeaceHealth

  https://www.peacehealth.org/medical-topics/id/cdc37

  RSV vaccine can prevent lower respiratory tract disease caused by respiratory syncytial virus (RSV). RSV is a common respiratory virus that usually causes mild, cold-like symptoms. […] Symptoms of RSV infection may include runny nose, decreased appetite, coughing, sneezing, fever, or wheezing. In very young infants, symptoms of RSV may also include irritability (fussiness), decreased activity, or apnea (pauses in breathing for more than 10 seconds). […] Most people recover in a week or two, but RSV can be more serious, resulting in shortness of breath and low oxygen levels. RSV can cause bronchiolitis (inflammation of the small airways in the lung) and pneumonia (infection of the lungs). RSV can also lead to worsening of other medical conditions such as asthma, chronic obstructive pulmonary disease (a chronic disease of the lungs that makes it hard to breathe), or heart failure (when the heart cannot pump enough blood and oxygen throughout the body).

• #11 RSV (Respiratory Syncytial Virus) Vaccine: MedlinePlus Drug InformationLock

  https://medlineplus.gov/druginfo/meds/a623035.html

  RSV vaccine can prevent disease caused by infection with Respiratory Syncytial Virus (RSV). […] Mild symptoms of RSV disease typically resolve in a week or two and include the following: runny nose, decrease in appetite, coughing, sneezing, fever, wheezing. […] In individuals at high risk of serious disease as previously described, RSV may cause shortness of breath and low oxygen levels or may also worsen chronic heart or lung disease, leading to a hospital stay and even potentially death. […] Side effects that have been reported with RSV vaccine include: Redness, swelling, pain, or tenderness where the shot is given, fever, feeling tired, headache, nausea, diarrhea, muscle or joint pain. […] Serious neurologic reactions, including Guillan-Barre Syndrome (GBS), have been reported very rarely after RSV vaccine in clinical trials. […] An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital.

• #12 What to know about RSV, RSV vaccine – Mayo Clinic Health System

  https://www.mayoclinichealthsystem.org/hometown-health/featured-topic/what-parents-should-know-about-rsv

  Respiratory syncytial virus, or RSV, is a common virus that most people will get by age 2. It causes mild cold symptoms for most people, who usually recover in a week or so. […] RSV can be serious for infants and older adults, however. When severe, it can lead to bronchiolitis or pneumonia. Bronchiolitis, or inflammation of the airway, is one of the most common causes of children needing hospitalization in the winter months. […] Symptoms of RSV can be similar to other viruses, like a cold or the flu, and may include: Dry cough, Low-grade fever, Mild headache, Runny nose or congestion, Sore throat, Wheezing or difficulty breathing. […] A child with RSV may not want to eat or drink as often as usual and may be more lethargic or sleepy. […] For most children who develop RSV, home remedies can ease symptoms. RSV symptoms usually last from two to eight days, but some children might have a cough for a few weeks before fully recovering. […] Seek immediate care for a child with RSV if they develop these symptoms: Breathing that is fast, shallow or noisy, Extreme irritability, High fever, Significant decrease in eating or drinking. […] Babies and young children can become very sick quickly due to RSV.

• #13 RSV (Respiratory Syncytial Virus) Vaccine: What You Need to Know – Advanced OB-GYN – Syracuse, NY – Auburn and Central New York| Dr. Myron Luthringer | da Vinci Hysterectomy | da Vinci Myomectomy | da Vinci Sacrocolpopexy | Minimally Invasive Robotic Surg

  https://www.advancedob-gyn.com/health-library/hw-view.php?DOCHWID=cdc37

  RSV vaccine can prevent lower respiratory tract disease caused by respiratory syncytial virus (RSV). RSV is a common respiratory virus that usually causes mild, cold-like symptoms. […] Symptoms of RSV infection may include runny nose, decreased appetite, coughing, sneezing, fever, or wheezing. In very young infants, symptoms of RSV may also include irritability (fussiness), decreased activity, or apnea (pauses in breathing for more than 10 seconds). […] Most people recover in a week or two, but RSV can be more serious, resulting in shortness of breath and low oxygen levels. RSV can cause bronchiolitis (inflammation of the small airways in the lung) and pneumonia (infection of the lungs). RSV can also lead to worsening of other medical conditions such as asthma, chronic obstructive pulmonary disease (a chronic disease of the lungs that makes it hard to breathe), or heart failure (when the heart cannot pump enough blood and oxygen throughout the body).

• #14 RSV: Symptoms & Treatment | Kaiser Permanente

  https://healthy.kaiserpermanente.org/southern-california/health-wellness/rsv

  Most children will get an RSV infection with mild symptoms by the time theyre 2. […] Symptoms of RSV usually appear within 4 to 6 days after infection. Mild, cold-like symptoms typically include: Congested or runny nose, Decreased appetite, Coughing, Sneezing, Fever, Moderate wheezing. […] Severe symptoms to look out for in children include: Severe wheezing, Rapid breathing or respiratory distress, Bluish skin or fingernails, Refusal to drink liquids, Decreased number of wet diapers, Extreme tiredness. […] Some people with an RSV infection, especially older adults and infants under 6 months, may develop a lung infection, get dehydrated, or have trouble breathing. […] Older adults are at greater risk than young adults for serious complications from RSV because their immune systems are weaker.

• #15 RSV (Respiratory Syncytial Virus) Vaccine: What You Need to Know – Health Information Library | PeaceHealth

  https://www.peacehealth.org/medical-topics/id/cdc37

  RSV vaccine can prevent lower respiratory tract disease caused by respiratory syncytial virus (RSV). RSV is a common respiratory virus that usually causes mild, cold-like symptoms. […] Symptoms of RSV infection may include runny nose, decreased appetite, coughing, sneezing, fever, or wheezing. In very young infants, symptoms of RSV may also include irritability (fussiness), decreased activity, or apnea (pauses in breathing for more than 10 seconds). […] Most people recover in a week or two, but RSV can be more serious, resulting in shortness of breath and low oxygen levels. RSV can cause bronchiolitis (inflammation of the small airways in the lung) and pneumonia (infection of the lungs). RSV can also lead to worsening of other medical conditions such as asthma, chronic obstructive pulmonary disease (a chronic disease of the lungs that makes it hard to breathe), or heart failure (when the heart cannot pump enough blood and oxygen throughout the body).

• #16 RSV symptoms, care and treatment | OHSU

  https://www.ohsu.edu/health/rsv-respiratory-syncytial-virus

  RSV symptoms show up four to six days after someone gets infected. […] Cold symptoms usually appear first. They include: Cough, Fever, Runny or stuffy nose, Sneezing, Low appetite, Fussiness in babies and toddlers. […] Cold symptoms may be followed by symptoms of pneumonia or bronchiolitis, both lung infections. These symptoms include breathing that: Is faster than normal, May include: Flaring nostrils and nodding head, Grunting, Wheezing, Ribs pulling in with each breath. […] Most children can recover at home over a week or two. […] Seek emergency care for your child if: The inside of the child’s mouth is a bluish tint, Their breathing is extremely labored, They aren’t taking in or holding down fluids and haven’t urinated in eight hours, They are severely lethargic and you are struggling to wake them.

• #17 RSV (Respiratory Syncytial Virus) Vaccine: What You Need to Know – Advanced OB-GYN – Syracuse, NY – Auburn and Central New York| Dr. Myron Luthringer | da Vinci Hysterectomy | da Vinci Myomectomy | da Vinci Sacrocolpopexy | Minimally Invasive Robotic Surg

  https://www.advancedob-gyn.com/health-library/hw-view.php?DOCHWID=cdc37

  RSV vaccine can prevent lower respiratory tract disease caused by respiratory syncytial virus (RSV). RSV is a common respiratory virus that usually causes mild, cold-like symptoms. […] Symptoms of RSV infection may include runny nose, decreased appetite, coughing, sneezing, fever, or wheezing. In very young infants, symptoms of RSV may also include irritability (fussiness), decreased activity, or apnea (pauses in breathing for more than 10 seconds). […] Most people recover in a week or two, but RSV can be more serious, resulting in shortness of breath and low oxygen levels. RSV can cause bronchiolitis (inflammation of the small airways in the lung) and pneumonia (infection of the lungs). RSV can also lead to worsening of other medical conditions such as asthma, chronic obstructive pulmonary disease (a chronic disease of the lungs that makes it hard to breathe), or heart failure (when the heart cannot pump enough blood and oxygen throughout the body).

• #18 RSV Symptoms, Treatment & Vaccines | University Hospitals | University Hospitals

  https://www.uhhospitals.org/services/rsv-treatment-services

  RSV Symptoms RSV Vaccine Symptoms of RSV can be very similar to those of the common cold and other respiratory viruses. They include: Congestion, Cough, Fatigue, Fever, Headache, Poor appetite, Runny nose, Sneezing, Sore throat, Wheezing. […] Young infants under 6 months old may experience symptoms such as: Fussiness/irritability, Decreased activity, Breathing pattern changes, including pauses in breathing (apnea). […] When RSV spreads to the lower respiratory tract it can cause more severe symptoms that may require hospitalization. These include: Bronchiolitis (inflammation of the small airways in the lung), Pneumonia, Acute bronchitis, Difficulty breathing, Low oxygen levels, Worsening of symptoms associated with conditions such as asthma, chronic pulmonary obstructive disorder (COPD) and congestive heart failure, Can lead to cardiac disease, bacterial infections and death.

• #19 Respiratory Syncytial Virus (RSV) – Epidemiology

  https://www.vdh.virginia.gov/epidemiology/epidemiology-fact-sheets/respiratory-syncytial-virus-rsv/

  The symptoms of RSV usually appear in stages and not all at once. Symptoms of RSV infection usually include: […] In very young infants with RSV, the only symptoms may be irritability, decreased activity, and breathing difficulties. Out of every one hundred infants who get RSV, about 2-3 of them will need to be hospitalized. Older adults with a more severe case of RSV may have difficulty breathing or worsening of an underlying heart or lung disease. This may result in hospitalization. […] One of the first signs of a more serious illness can be rapid breathing or a cough with wheezing. It means that the virus has spread to the lower respiratory tract (the lungs). This can lead to inflammation of the small airways in the lungs (bronchiolitis) or a lung infection (pneumonia).

• #20 RSV Symptoms, Treatment & Vaccines | University Hospitals | University Hospitals

  https://www.uhhospitals.org/services/rsv-treatment-services

  RSV Symptoms RSV Vaccine Symptoms of RSV can be very similar to those of the common cold and other respiratory viruses. They include: Congestion, Cough, Fatigue, Fever, Headache, Poor appetite, Runny nose, Sneezing, Sore throat, Wheezing. […] Young infants under 6 months old may experience symptoms such as: Fussiness/irritability, Decreased activity, Breathing pattern changes, including pauses in breathing (apnea). […] When RSV spreads to the lower respiratory tract it can cause more severe symptoms that may require hospitalization. These include: Bronchiolitis (inflammation of the small airways in the lung), Pneumonia, Acute bronchitis, Difficulty breathing, Low oxygen levels, Worsening of symptoms associated with conditions such as asthma, chronic pulmonary obstructive disorder (COPD) and congestive heart failure, Can lead to cardiac disease, bacterial infections and death.

• #21 Respiratory Syncytial Virus (RSV) in Children | Cedars-Sinai

  https://www.cedars-sinai.org/health-library/diseases-and-conditions—pediatrics/r/respiratory-syncytial-virus-rsv-in-children.html

  RSV is a viral illness that causes symptoms such as trouble breathing. Its the most common cause of inflammation of the small airways in the lungs (bronchiolitis) and pneumonia in babies. […] Symptoms start about 2 to 5 days after contact with the virus. […] The early phase of RSV in babies and young children is often mild, like a cold. In children younger than age 3, the illness may move into the lungs and cause coughing and wheezing. In some children, the infection turns to a severe respiratory disease. Your child may need to be treated in the hospital to help with breathing. […] The most common symptoms of RSV include: Runny nose, Fever, Cough, Short periods without breathing (apnea), Trouble eating, drinking, or swallowing, Wheezing, Flaring of the nostrils or straining of the chest or stomach while breathing, Breathing faster than normal, or trouble breathing, Turning blue around the lips and fingertips.

• #22 Respiratory Syncytial Virus (RSV) – Epidemiology

  https://www.vdh.virginia.gov/epidemiology/epidemiology-fact-sheets/respiratory-syncytial-virus-rsv/

  The symptoms of RSV usually appear in stages and not all at once. Symptoms of RSV infection usually include: […] In very young infants with RSV, the only symptoms may be irritability, decreased activity, and breathing difficulties. Out of every one hundred infants who get RSV, about 2-3 of them will need to be hospitalized. Older adults with a more severe case of RSV may have difficulty breathing or worsening of an underlying heart or lung disease. This may result in hospitalization. […] One of the first signs of a more serious illness can be rapid breathing or a cough with wheezing. It means that the virus has spread to the lower respiratory tract (the lungs). This can lead to inflammation of the small airways in the lungs (bronchiolitis) or a lung infection (pneumonia).

• #23 What to know about RSV, RSV vaccine – Mayo Clinic Health System

  https://www.mayoclinichealthsystem.org/hometown-health/featured-topic/what-parents-should-know-about-rsv

  Respiratory syncytial virus, or RSV, is a common virus that most people will get by age 2. It causes mild cold symptoms for most people, who usually recover in a week or so. […] RSV can be serious for infants and older adults, however. When severe, it can lead to bronchiolitis or pneumonia. Bronchiolitis, or inflammation of the airway, is one of the most common causes of children needing hospitalization in the winter months. […] Symptoms of RSV can be similar to other viruses, like a cold or the flu, and may include: Dry cough, Low-grade fever, Mild headache, Runny nose or congestion, Sore throat, Wheezing or difficulty breathing. […] A child with RSV may not want to eat or drink as often as usual and may be more lethargic or sleepy. […] For most children who develop RSV, home remedies can ease symptoms. RSV symptoms usually last from two to eight days, but some children might have a cough for a few weeks before fully recovering. […] Seek immediate care for a child with RSV if they develop these symptoms: Breathing that is fast, shallow or noisy, Extreme irritability, High fever, Significant decrease in eating or drinking. […] Babies and young children can become very sick quickly due to RSV.

• #24 What to know about RSV, RSV vaccine – Mayo Clinic Health System

  https://www.mayoclinichealthsystem.org/hometown-health/featured-topic/what-parents-should-know-about-rsv

  Respiratory syncytial virus, or RSV, is a common virus that most people will get by age 2. It causes mild cold symptoms for most people, who usually recover in a week or so. […] RSV can be serious for infants and older adults, however. When severe, it can lead to bronchiolitis or pneumonia. Bronchiolitis, or inflammation of the airway, is one of the most common causes of children needing hospitalization in the winter months. […] Symptoms of RSV can be similar to other viruses, like a cold or the flu, and may include: Dry cough, Low-grade fever, Mild headache, Runny nose or congestion, Sore throat, Wheezing or difficulty breathing. […] A child with RSV may not want to eat or drink as often as usual and may be more lethargic or sleepy. […] For most children who develop RSV, home remedies can ease symptoms. RSV symptoms usually last from two to eight days, but some children might have a cough for a few weeks before fully recovering. […] Seek immediate care for a child with RSV if they develop these symptoms: Breathing that is fast, shallow or noisy, Extreme irritability, High fever, Significant decrease in eating or drinking. […] Babies and young children can become very sick quickly due to RSV.

• #25 LAC | DPH – Vaccine Preventable Disease Control Program

  http://ph.lacounty.gov/ip/diseases/RSV/index.htm

  RSV infection can cause a variety of respiratory illnesses and symptoms in infants and young children. It most commonly causes a cold-like illness but can also cause lower respiratory infections, like bronchiolitis and pneumonia. In adults, symptoms are usually consistent with an upper respiratory tract infection, which can include rhinorrhea, pharyngitis, cough, headache, fatigue, and fever. Milder illness in adults typically resolves in 12 weeks. However, RSV can also cause severe pulmonary disease and hospitalization in older adults and those with underlying conditions.

• #26 RSV (Respiratory Syncytial Virus) Vaccine: MedlinePlus Drug InformationLock

  https://medlineplus.gov/druginfo/meds/a623035.html

  RSV vaccine can prevent disease caused by infection with Respiratory Syncytial Virus (RSV). […] Mild symptoms of RSV disease typically resolve in a week or two and include the following: runny nose, decrease in appetite, coughing, sneezing, fever, wheezing. […] In individuals at high risk of serious disease as previously described, RSV may cause shortness of breath and low oxygen levels or may also worsen chronic heart or lung disease, leading to a hospital stay and even potentially death. […] Side effects that have been reported with RSV vaccine include: Redness, swelling, pain, or tenderness where the shot is given, fever, feeling tired, headache, nausea, diarrhea, muscle or joint pain. […] Serious neurologic reactions, including Guillan-Barre Syndrome (GBS), have been reported very rarely after RSV vaccine in clinical trials. […] An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital.

• #27 What to know about RSV, RSV vaccine – Mayo Clinic Health System

  https://www.mayoclinichealthsystem.org/hometown-health/featured-topic/what-parents-should-know-about-rsv

  Respiratory syncytial virus, or RSV, is a common virus that most people will get by age 2. It causes mild cold symptoms for most people, who usually recover in a week or so. […] RSV can be serious for infants and older adults, however. When severe, it can lead to bronchiolitis or pneumonia. Bronchiolitis, or inflammation of the airway, is one of the most common causes of children needing hospitalization in the winter months. […] Symptoms of RSV can be similar to other viruses, like a cold or the flu, and may include: Dry cough, Low-grade fever, Mild headache, Runny nose or congestion, Sore throat, Wheezing or difficulty breathing. […] A child with RSV may not want to eat or drink as often as usual and may be more lethargic or sleepy. […] For most children who develop RSV, home remedies can ease symptoms. RSV symptoms usually last from two to eight days, but some children might have a cough for a few weeks before fully recovering. […] Seek immediate care for a child with RSV if they develop these symptoms: Breathing that is fast, shallow or noisy, Extreme irritability, High fever, Significant decrease in eating or drinking. […] Babies and young children can become very sick quickly due to RSV.

• #28 RSV Symptoms, Treatment & Vaccines | University Hospitals | University Hospitals

  https://www.uhhospitals.org/services/rsv-treatment-services

  RSV Symptoms RSV Vaccine Symptoms of RSV can be very similar to those of the common cold and other respiratory viruses. They include: Congestion, Cough, Fatigue, Fever, Headache, Poor appetite, Runny nose, Sneezing, Sore throat, Wheezing. […] Young infants under 6 months old may experience symptoms such as: Fussiness/irritability, Decreased activity, Breathing pattern changes, including pauses in breathing (apnea). […] When RSV spreads to the lower respiratory tract it can cause more severe symptoms that may require hospitalization. These include: Bronchiolitis (inflammation of the small airways in the lung), Pneumonia, Acute bronchitis, Difficulty breathing, Low oxygen levels, Worsening of symptoms associated with conditions such as asthma, chronic pulmonary obstructive disorder (COPD) and congestive heart failure, Can lead to cardiac disease, bacterial infections and death.

• #29 Side Effects of RSV Vaccines: What’s Normal, What’s Not

  https://www.aarp.org/health/conditions-treatments/rsv-vaccine-side-effects/

  RSV typically causes cold-like symptoms, but in some cases, those symptoms can progress to a lung infection or pneumonia. RSV can worsen other health conditions such as asthma or chronic obstructive pulmonary disease (COPD). […] The CDC estimates that RSV sends 177,000 older Americans to the hospital annually; about 14,000 older adults die each year from an RSV infection. […] GBS was flagged as a rare side effect in the clinical trials testing the RSV vaccines. […] The latest data does not change recommendations, because the risk of RSV serious infection in these highly vulnerable populations is vastly greater than is the risk of Guillain-Barr.

• #30 RSV (Respiratory Syncytial Virus) Vaccine: What You Need to Know – Health Information Library | PeaceHealth

  https://www.peacehealth.org/medical-topics/id/cdc37

  RSV vaccine can prevent lower respiratory tract disease caused by respiratory syncytial virus (RSV). RSV is a common respiratory virus that usually causes mild, cold-like symptoms. […] Symptoms of RSV infection may include runny nose, decreased appetite, coughing, sneezing, fever, or wheezing. In very young infants, symptoms of RSV may also include irritability (fussiness), decreased activity, or apnea (pauses in breathing for more than 10 seconds). […] Most people recover in a week or two, but RSV can be more serious, resulting in shortness of breath and low oxygen levels. RSV can cause bronchiolitis (inflammation of the small airways in the lung) and pneumonia (infection of the lungs). RSV can also lead to worsening of other medical conditions such as asthma, chronic obstructive pulmonary disease (a chronic disease of the lungs that makes it hard to breathe), or heart failure (when the heart cannot pump enough blood and oxygen throughout the body).

• #31 Respiratory Syncytial Virus (RSV) in Children | Cedars-Sinai

  https://www.cedars-sinai.org/health-library/diseases-and-conditions—pediatrics/r/respiratory-syncytial-virus-rsv-in-children.html

  Treatment for RSV may include extra oxygen. This is extra oxygen given through a mask, nasal prongs, or an oxygen tent. A child who is very ill may need to be put on a breathing machine (ventilator) to help with breathing. […] In high-risk babies, RSV can lead to severe respiratory illness and pneumonia. This may become life-threatening. RSV as a baby may be linked to asthma later in childhood.

• #32 The RSV vaccine in the elderly: Preventing is better than curing. | Bangkok Hospital Headquarter

  https://www.bangkokhospital.com/en/content/rsv-vaccine-for-older-adults

  What are the symptoms of RSV in the elderly? Fever, Dry cough, chronic cough, Nasal congestion, runny nose, Shortness of breath, weakness, fatigue, Rapid breathing, wheezing, Loss of appetite, Delirium, confusion. […] There is no specific treatment for RSV; the focus is on symptomatic treatment. In cases of mild symptoms, doctors will prescribe fever reducers and expectorants and advise resting fully. However, if symptoms are severe, such as persistent fever, difficulty breathing, or decreased alertness, it is necessary to see a doctor immediately as oxygen supplementation and hospital observation might be required to monitor symptoms closely. […] If an elderly person contracts RSV, there is a risk of complications, potentially being severe enough to cause death, such as pneumonia, heart failure, or bacterial infection complications.

• #33 RSV vaccine for adults | NHS inform

  https://www.nhsinform.scot/healthy-living/immunisation/vaccines/rsv-vaccine-for-adults/

  The RSV vaccine helps protect you by reducing your chances of getting an RSV infection. […] The RSV vaccine helps build up your immunity to the virus. This means your body will fight off the infection more easily. […] Like all medicines, no vaccine is completely effective. Theres still a chance you might get RSV after having the vaccine. However, its likely to be milder and not last as long. […] After having the vaccine you may have some side effects. These are usually mild and disappear within a few days. […] Around the injection site you might experience: pain, redness, swelling. […] Other side effects are rare. In the first season of use in the US, over 12 million doses of RSV vaccine were given. A rare nervous system condition that leads to weakness, known as Guillain-Barr syndrome, was reported in around 10 cases for every million doses of vaccine given. The same condition also occurs after a number of common infections and, rarely, after some other vaccines. […] Overall, it is safer for you to receive the vaccine than to risk having a potentially serious RSV infection.

• #34 RSV Vaccine: What It Is, Who Should Get It, Cost

  https://www.everydayhealth.com/lung-respiratory/respiratory-syncytial-virus-vaccine/

  The RSV vaccine protects against RSV (respiratory syncytial virus), a common seasonal virus that infects the nose, throat, and lungs. […] While RSV typically causes mild, cold-like symptoms, it can lead to serious and even fatal illness, especially in infants and older adults. […] The effectiveness of the RSV vaccine depends on the age of the recipient and the type of vaccine. […] The CDC says that studies of the real-world effectiveness of Arexvy during the 20232024 respiratory virus season showed the vaccine to be about 77 percent effective in preventing RSV-associated emergency room visits and 83 percent effective in preventing RSV-associated hospitalizations in adults 60 and older. […] Abrysvo was found to be about 79 percent effective in preventing RSV-associated emergency room visits and 73 percent effective in preventing RSV-related hospitalizations in adults 60 and older.

• #35 RSV vaccines: Questions patients may have and how to answer | American Medical Association

  https://www.ama-assn.org/delivering-care/public-health/rsv-vaccines-questions-patients-may-have-and-how-answer

  RSV generally causes mild upper respiratory disease in healthy adults. But for adults 60 or older with certain underlying conditions or other risk factors, RSV can cause serious illness. […] Some of the common side effects include fatigue, fever, headache, muscle or joint pain, nausea and diarrhea. The side effects are typically mild, says the CDC. […] A small number of participants in clinical trials developed serious neurologic conditions, including Guillain-Barr syndrome (GBS), after receiving GSK’s Arexvy or Pfizer’s Abrysvo. Available data support existence of an increased risk of GBS after RSV vaccination with both GSKs Arexvy and Pfizers Abrysvo. […] However, there is still uncertainty in the amount of increased GBS risk with these vaccines. While there were no reports of GBS among adults who received Moderna’s mResvia vaccine in clinical trials, a similar safety signal cannot be ruled out.

• #36 Respiratory syncytial virus (RSV) vaccine | HealthLink BC

  https://immunizebc.ca/vaccines/respiratory-syncytial-virus-rsv

  These medications provide immediate but temporary protection. Nirsevimab can protect infants for up to 5 months after it is provided. […] The purpose of the vaccine during pregnancy is to protect the baby after birth. When a pregnant person receives the vaccine, their body produces antibodies that pass through the placenta to the baby, providing passive immunity. This gives the baby early protection against RSV during the first few months of life, when they are most vulnerable. […] ABRYSVO is an inactivated (non-live) vaccine that is safe for pregnant people and their developing babies. It is the only vaccine approved for use in pregnancy that has been intentionally tested in pregnant people during clinical trials. Other RSV vaccines are not approved for use in pregnancy.

• #37 RSV Vaccine Guidance for Older Adults | RSV | CDC

  https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/older-adults.html

  CDC recommends a single dose of RSV vaccine for older adults to help prevent serious RSV infection and hospitalization. […] The RSV vaccine is not currently an annual vaccine, meaning eligible adults do not need to get a dose every RSV season. […] Adverse events after RSV vaccination should be reported to the Vaccine Adverse Event Reporting System (VAERS), even if it is not clear that the vaccine caused the adverse event. […] Coadministration of RSV vaccine with one or more adult vaccines during the same visit may increase common side effects (e.g., pain at the injection site, fever, headache, myalgia). […] Data on immunogenicity of RSV vaccines and other vaccines when coadministered are currently limited. These limited data show coadministration of RSV with other respiratory virus vaccines may result in lower antibody titers, but the clinical significance of this is unknown.

• #38 Vaccines for Older Adults | RSV | CDC

  https://www.cdc.gov/rsv/vaccines/older-adults.html

  CDC recommends everyone ages 75 and older get an RSV vaccine. […] CDC recommends adults ages 60-74 who are at increased risk of severe RSV disease get an RSV vaccine. […] The RSV vaccine is not currently an annual vaccine. […] Side effects such as pain, redness, and swelling where the shot is given, fatigue, fever, headache, nausea, diarrhea, and muscle or joint pain may occur after you get an RSV vaccine. […] A small number of participants in clinical trials developed serious neurologic conditions, including Guillain-Barr syndrome (GBS), after receiving GSK’s Arexvy or Pfizer’s Abrysvo. […] The Advisory Committee on Immunization Practices (ACIP) concluded that the available data support existence of an increased risk of GBS after RSV vaccination with both GSK’s Arexvy and Pfizer’s Abrysvo.

• #39 Everything You Need to Know About the RSV Vaccine | ColumbiaDoctors

  https://www.columbiadoctors.org/news/everything-you-need-know-about-rsv-vaccine

  According to the FDA, the Arexvy vaccine reduces the risk of developing RSV-associated LRTD (lower respiratory tract disease) by 82.6% and the risk of developing severe RSV-associated LRTD by 94.1%. […] Yes. Theres a new vaccine for infants and very young children. A monoclonal antibody immunization called nirsevimab was approved for infants younger than 8 months (who are experiencing their first RSV season this winter). Multiple studies show nirsevimab reduces hospitalizations and severe infections in infants.

• #40 RSV Vaccine: What It Is, Who Should Get It, Cost

  https://www.everydayhealth.com/lung-respiratory/respiratory-syncytial-virus-vaccine/

  The RSV vaccine protects against RSV (respiratory syncytial virus), a common seasonal virus that infects the nose, throat, and lungs. […] While RSV typically causes mild, cold-like symptoms, it can lead to serious and even fatal illness, especially in infants and older adults. […] The effectiveness of the RSV vaccine depends on the age of the recipient and the type of vaccine. […] The CDC says that studies of the real-world effectiveness of Arexvy during the 20232024 respiratory virus season showed the vaccine to be about 77 percent effective in preventing RSV-associated emergency room visits and 83 percent effective in preventing RSV-associated hospitalizations in adults 60 and older. […] Abrysvo was found to be about 79 percent effective in preventing RSV-associated emergency room visits and 73 percent effective in preventing RSV-related hospitalizations in adults 60 and older.

• #41 RSV Vaccine: What It Is, Who Should Get It, Cost

  https://www.everydayhealth.com/lung-respiratory/respiratory-syncytial-virus-vaccine/

  The RSV vaccine protects against RSV (respiratory syncytial virus), a common seasonal virus that infects the nose, throat, and lungs. […] While RSV typically causes mild, cold-like symptoms, it can lead to serious and even fatal illness, especially in infants and older adults. […] The effectiveness of the RSV vaccine depends on the age of the recipient and the type of vaccine. […] The CDC says that studies of the real-world effectiveness of Arexvy during the 20232024 respiratory virus season showed the vaccine to be about 77 percent effective in preventing RSV-associated emergency room visits and 83 percent effective in preventing RSV-associated hospitalizations in adults 60 and older. […] Abrysvo was found to be about 79 percent effective in preventing RSV-associated emergency room visits and 73 percent effective in preventing RSV-related hospitalizations in adults 60 and older.

• #42 RSV Vaccine: What It Is, Who Should Get It, Cost

  https://www.everydayhealth.com/lung-respiratory/respiratory-syncytial-virus-vaccine/

  In a study of pregnant individuals who received Abrysvo, newborns had nearly an 82 percent reduced risk of severe lower respiratory tract infection within 90 days after birth if their mother had been vaccinated. […] Because mRESVIA is so new, research data is more limited. A clinical trial of participants ages 60 and older, however, found that the efficacy of a single dose of mResvia against symptomatic RSV was about 80 percent during the first four months following vaccination and about 56 percent during the first 12 months after vaccination. […] The FDA has deemed RSV vaccination to be both safe and effective after an evaluation of data from clinical trials. […] But the CDC notes that a small number of trial participants developed serious neurological conditions, including Guillain-Barr syndrome (GBS), after receiving Arexvy or Abrysvo.

• #43 Respiratory syncytial virus (RSV) FAQs | NCIRS

  https://ncirs.org.au/ncirs-fact-sheets-faqs-and-other-resources/respiratory-syncytial-virus-rsv-frequently-asked

  RSV is a common virus that can infect people of all ages. It can cause a range of respiratory illnesses from mild upper respiratory colds to severe lower respiratory conditions like bronchiolitis, bronchitis or pneumonia. Symptoms of RSV disease can include: runny nose, cough, fever, wheezing and difficulty breathing (including exacerbations of underlying lung disease such as asthma). […] Clinical trials for Abyrsvo have shown that use of the Abrysvo vaccine in pregnant women provided infants with good protection from severe RSV; the risk of hospitalisation from RSV infection was reduced by around 60% in infants during their first 6 months of life. […] Clinical trials for Arexvy, Abrysvo and mRESVIA (Moderna; not yet available in Australia) showed good protection against severe RSV disease in adults aged 60 years and over, with around an 80-95% reduction in the risk of severe lower respiratory tract disease in vaccinated individuals.

• #44 RSV Vaccine: What It Is, Who Should Get It, Cost

  https://www.everydayhealth.com/lung-respiratory/respiratory-syncytial-virus-vaccine/

  In a study of pregnant individuals who received Abrysvo, newborns had nearly an 82 percent reduced risk of severe lower respiratory tract infection within 90 days after birth if their mother had been vaccinated. […] Because mRESVIA is so new, research data is more limited. A clinical trial of participants ages 60 and older, however, found that the efficacy of a single dose of mResvia against symptomatic RSV was about 80 percent during the first four months following vaccination and about 56 percent during the first 12 months after vaccination. […] The FDA has deemed RSV vaccination to be both safe and effective after an evaluation of data from clinical trials. […] But the CDC notes that a small number of trial participants developed serious neurological conditions, including Guillain-Barr syndrome (GBS), after receiving Arexvy or Abrysvo.

• #45 RSV vaccine for adults | NHS inform

  https://www.nhsinform.scot/healthy-living/immunisation/vaccines/rsv-vaccine-for-adults/

  The RSV vaccine helps protect you by reducing your chances of getting an RSV infection. […] The RSV vaccine helps build up your immunity to the virus. This means your body will fight off the infection more easily. […] Like all medicines, no vaccine is completely effective. Theres still a chance you might get RSV after having the vaccine. However, its likely to be milder and not last as long. […] After having the vaccine you may have some side effects. These are usually mild and disappear within a few days. […] Around the injection site you might experience: pain, redness, swelling. […] Other side effects are rare. In the first season of use in the US, over 12 million doses of RSV vaccine were given. A rare nervous system condition that leads to weakness, known as Guillain-Barr syndrome, was reported in around 10 cases for every million doses of vaccine given. The same condition also occurs after a number of common infections and, rarely, after some other vaccines. […] Overall, it is safer for you to receive the vaccine than to risk having a potentially serious RSV infection.

• #46 Frequently Asked Questions

  https://www.nhsborders.scot.nhs.uk/patients-and-visitors/respiratory-syncytial-virus-(rsv)/frequently-asked-questions/

  RSV, also known as Respiratory Syncytial Virus, is a common respiratory illness affecting the airways and lungs. RSV can make you wheezy and short of breath but can also lead to more serious illnesses such as pneumonia and other life-threatening conditions. […] It is possible to catch RSV after having the vaccine, but symptoms are likely to be mild and not last as long. It can take a few days for your body to build up extra protection from the vaccination. […] You might have some side effects after having the vaccine, these are usually mild and disappear within a few days. This shows the vaccine is working and teaching your bodys immune system how to protect itself from the RSV virus. Side effects might include pain, swelling or redness at the site of injection, headache, feeling sick, tiredness. These can usually be managed by taking paracetamol and drinking fluids. A member of staff will discuss this with you at your appointment. Other side effects are rare.

• #47 RSV vaccine for adults | NHS inform

  https://www.nhsinform.scot/healthy-living/immunisation/vaccines/rsv-vaccine-for-adults/

  The RSV vaccine helps protect you by reducing your chances of getting an RSV infection. […] The RSV vaccine helps build up your immunity to the virus. This means your body will fight off the infection more easily. […] Like all medicines, no vaccine is completely effective. Theres still a chance you might get RSV after having the vaccine. However, its likely to be milder and not last as long. […] After having the vaccine you may have some side effects. These are usually mild and disappear within a few days. […] Around the injection site you might experience: pain, redness, swelling. […] Other side effects are rare. In the first season of use in the US, over 12 million doses of RSV vaccine were given. A rare nervous system condition that leads to weakness, known as Guillain-Barr syndrome, was reported in around 10 cases for every million doses of vaccine given. The same condition also occurs after a number of common infections and, rarely, after some other vaccines. […] Overall, it is safer for you to receive the vaccine than to risk having a potentially serious RSV infection.

• #48 Side Effects of RSV Vaccines: What’s Normal, What’s Not

  https://www.aarp.org/health/conditions-treatments/info-2024/rsv-vaccine-side-effects.html

  The common side effects of RSV vaccines that have been reported in clinical trials and through the national Vaccine Adverse Event Reporting System (VAERS) are similar to the common symptoms people experience after a flu shot or COVID-19 vaccine. They include: Injection site pain, Fatigue, Muscle pain, Headache, Joint stiffness/pain, Nausea. […] These post-shot symptoms can happen with any vaccine, says William Schaffner, M.D., a professor of medicine at Vanderbilt University School of Medicine in Nashville, Tennessee, and theyre generally a sign that the body is mounting an immune response. […] Serious side effects from vaccines are uncommon, but they can happen. A new report from the Centers for Disease Control and Prevention (CDC) finds that a small number of older adults developed a rare neurological disorder known as Guillain-Barr syndrome (GBS) after RSV vaccination.

• #49 RSV (Respiratory Syncytial Virus) Vaccine: MedlinePlus Drug InformationLock

  https://medlineplus.gov/druginfo/meds/a623035.html

  RSV vaccine can prevent disease caused by infection with Respiratory Syncytial Virus (RSV). […] Mild symptoms of RSV disease typically resolve in a week or two and include the following: runny nose, decrease in appetite, coughing, sneezing, fever, wheezing. […] In individuals at high risk of serious disease as previously described, RSV may cause shortness of breath and low oxygen levels or may also worsen chronic heart or lung disease, leading to a hospital stay and even potentially death. […] Side effects that have been reported with RSV vaccine include: Redness, swelling, pain, or tenderness where the shot is given, fever, feeling tired, headache, nausea, diarrhea, muscle or joint pain. […] Serious neurologic reactions, including Guillan-Barre Syndrome (GBS), have been reported very rarely after RSV vaccine in clinical trials. […] An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital.

• #50 RSV (Respiratory Syncytial Virus) Vaccine: What You Need to Know – Advanced OB-GYN – Syracuse, NY – Auburn and Central New York| Dr. Myron Luthringer | da Vinci Hysterectomy | da Vinci Myomectomy | da Vinci Sacrocolpopexy | Minimally Invasive Robotic Surg

  https://www.advancedob-gyn.com/health-library/hw-view.php?DOCHWID=cdc37

  Pain, redness, and swelling where the shot is given, fatigue (feeling tired), fever, headache, nausea, diarrhea, and muscle or joint pain can happen after RSV vaccination. […] Serious neurologic conditions, including Guillain-Barré syndrome (GBS), have been reported after RSV vaccination in some older adults. At this time, an increased risk of GBS following RSV vaccine among persons aged 60 years and older cannot be confirmed or ruled out. […] Preterm birth and high blood pressure during pregnancy, including pre-eclampsia, have been reported among pregnant women who received RSV vaccine. It is unclear whether these events were caused by the vaccine. […] As with any medicine, there is a very remote chance of a vaccine causing a severe allergic reaction, other serious injury, or death.

• #51 RSV vaccine – NHS

  https://www.nhs.uk/vaccinations/rsv-vaccine/

  The RSV vaccine helps protect against respiratory syncytial virus (RSV), a common virus that can make babies and older adults seriously ill. […] The RSV vaccine helps reduce the risk of serious breathing problems like pneumonia and bronchiolitis. […] The most common side effects of the RSV vaccine are mild and do not last long. They can include: swelling or pain where the injection was given, a headache, an aching body. […] More serious side effects such as a severe allergic reaction are very rare. […] There have been very rare cases of Guillain-Barr syndrome (a condition that affects the nerves) in older adults who’ve had the RSV vaccine. But overall it’s safer for you to have the vaccine than risk having a potentially serious RSV infection.

• #52 Early Safety Findings Among Persons Aged ≥60 Years Who Received a Respiratory Syncytial Virus Vaccine — United States, May 3, 2023–April 14, 2024

  https://pmc.ncbi.nlm.nih.gov/articles/PMC11152365/

  The Food and Drug Administration licensed Arexvy and Abrysvo vaccines in May 2023 for prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in adults aged 60 years. In trials, Guillain-Barr syndrome (GBS) was identified as a potential safety concern. […] Findings are consistent with those from trials; reports of GBS (4.4 and 1.8 reports per million doses of Abrysvo and Arexvy vaccine administered, respectively) were more common than expected background rates. […] Among the 16,220 V-safe participants aged 60 years who reported receiving an RSV vaccine and completed one or more daily surveys, 39.0% reported at least one symptom after vaccination; 0.4% of participants reported receiving medical care. […] During the week after vaccination, 6,328 (39.0%) participants reported symptoms they considered possibly related to RSV vaccination. Injection site symptoms were reported by 2,808 (43.9%) participants who received GSK vaccine and 787 (20.3%) who received Pfizer vaccine. Most injection site symptoms were mild (3,351; 20.7%) or moderate (1,889; 11.6%). Systemic symptoms were reported by 2,344 (36.6%) who received GSK and 839 (21.6%) who received Pfizer. Most systemic symptoms were mild (1,997; 12.3%) or moderate (2,184; 13.5%). The most frequently reported symptoms after RSV vaccination were pain at or near the injection site (5,026; 31.0%), fatigue or tiredness (3,327; 20.5%), and muscle or body aches (2,843; 17.5%).

• #53 Early Safety Findings Among Persons Aged ≥60 Years Who Received a Respiratory Syncytial Virus Vaccine — United States, May 3, 2023–April 14, 2024

  https://pmc.ncbi.nlm.nih.gov/articles/PMC11152365/

  The Food and Drug Administration licensed Arexvy and Abrysvo vaccines in May 2023 for prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in adults aged 60 years. In trials, Guillain-Barr syndrome (GBS) was identified as a potential safety concern. […] Findings are consistent with those from trials; reports of GBS (4.4 and 1.8 reports per million doses of Abrysvo and Arexvy vaccine administered, respectively) were more common than expected background rates. […] Among the 16,220 V-safe participants aged 60 years who reported receiving an RSV vaccine and completed one or more daily surveys, 39.0% reported at least one symptom after vaccination; 0.4% of participants reported receiving medical care. […] During the week after vaccination, 6,328 (39.0%) participants reported symptoms they considered possibly related to RSV vaccination. Injection site symptoms were reported by 2,808 (43.9%) participants who received GSK vaccine and 787 (20.3%) who received Pfizer vaccine. Most injection site symptoms were mild (3,351; 20.7%) or moderate (1,889; 11.6%). Systemic symptoms were reported by 2,344 (36.6%) who received GSK and 839 (21.6%) who received Pfizer. Most systemic symptoms were mild (1,997; 12.3%) or moderate (2,184; 13.5%). The most frequently reported symptoms after RSV vaccination were pain at or near the injection site (5,026; 31.0%), fatigue or tiredness (3,327; 20.5%), and muscle or body aches (2,843; 17.5%).

• #54 Early Safety Findings Among Persons Aged ≥60 Years Who Received a Respiratory Syncytial Virus Vaccine — United States, May 3, 2023–April 14, 2024

  https://pmc.ncbi.nlm.nih.gov/articles/PMC11152365/

  The Food and Drug Administration licensed Arexvy and Abrysvo vaccines in May 2023 for prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in adults aged 60 years. In trials, Guillain-Barr syndrome (GBS) was identified as a potential safety concern. […] Findings are consistent with those from trials; reports of GBS (4.4 and 1.8 reports per million doses of Abrysvo and Arexvy vaccine administered, respectively) were more common than expected background rates. […] Among the 16,220 V-safe participants aged 60 years who reported receiving an RSV vaccine and completed one or more daily surveys, 39.0% reported at least one symptom after vaccination; 0.4% of participants reported receiving medical care. […] During the week after vaccination, 6,328 (39.0%) participants reported symptoms they considered possibly related to RSV vaccination. Injection site symptoms were reported by 2,808 (43.9%) participants who received GSK vaccine and 787 (20.3%) who received Pfizer vaccine. Most injection site symptoms were mild (3,351; 20.7%) or moderate (1,889; 11.6%). Systemic symptoms were reported by 2,344 (36.6%) who received GSK and 839 (21.6%) who received Pfizer. Most systemic symptoms were mild (1,997; 12.3%) or moderate (2,184; 13.5%). The most frequently reported symptoms after RSV vaccination were pain at or near the injection site (5,026; 31.0%), fatigue or tiredness (3,327; 20.5%), and muscle or body aches (2,843; 17.5%).

• #55 Vaccines for Older Adults | RSV | CDC

  https://www.cdc.gov/rsv/vaccines/older-adults.html

  CDC recommends everyone ages 75 and older get an RSV vaccine. […] CDC recommends adults ages 60-74 who are at increased risk of severe RSV disease get an RSV vaccine. […] The RSV vaccine is not currently an annual vaccine. […] Side effects such as pain, redness, and swelling where the shot is given, fatigue, fever, headache, nausea, diarrhea, and muscle or joint pain may occur after you get an RSV vaccine. […] A small number of participants in clinical trials developed serious neurologic conditions, including Guillain-Barr syndrome (GBS), after receiving GSK’s Arexvy or Pfizer’s Abrysvo. […] The Advisory Committee on Immunization Practices (ACIP) concluded that the available data support existence of an increased risk of GBS after RSV vaccination with both GSK’s Arexvy and Pfizer’s Abrysvo.

• #56 RSV vaccines: Questions patients may have and how to answer | American Medical Association

  https://www.ama-assn.org/delivering-care/public-health/rsv-vaccines-questions-patients-may-have-and-how-answer

  RSV generally causes mild upper respiratory disease in healthy adults. But for adults 60 or older with certain underlying conditions or other risk factors, RSV can cause serious illness. […] Some of the common side effects include fatigue, fever, headache, muscle or joint pain, nausea and diarrhea. The side effects are typically mild, says the CDC. […] A small number of participants in clinical trials developed serious neurologic conditions, including Guillain-Barr syndrome (GBS), after receiving GSK’s Arexvy or Pfizer’s Abrysvo. Available data support existence of an increased risk of GBS after RSV vaccination with both GSKs Arexvy and Pfizers Abrysvo. […] However, there is still uncertainty in the amount of increased GBS risk with these vaccines. While there were no reports of GBS among adults who received Moderna’s mResvia vaccine in clinical trials, a similar safety signal cannot be ruled out.

• #57 Vaccines for Older Adults | RSV | CDC

  https://www.cdc.gov/rsv/vaccines/older-adults.html

  CDC recommends everyone ages 75 and older get an RSV vaccine. […] CDC recommends adults ages 60-74 who are at increased risk of severe RSV disease get an RSV vaccine. […] The RSV vaccine is not currently an annual vaccine. […] Side effects such as pain, redness, and swelling where the shot is given, fatigue, fever, headache, nausea, diarrhea, and muscle or joint pain may occur after you get an RSV vaccine. […] A small number of participants in clinical trials developed serious neurologic conditions, including Guillain-Barr syndrome (GBS), after receiving GSK’s Arexvy or Pfizer’s Abrysvo. […] The Advisory Committee on Immunization Practices (ACIP) concluded that the available data support existence of an increased risk of GBS after RSV vaccination with both GSK’s Arexvy and Pfizer’s Abrysvo.

• #58 Vaccines for Older Adults | RSV | CDC

  https://www.cdc.gov/rsv/vaccines/older-adults.html

  While there is still uncertainty in the amount of increased GBS risk with these vaccines, ACIP understands that the GBS risk appears comparable to, and potentially greater than, that of other currently licensed and recommended adult vaccines. […] There were no reports of GBS among adults who received Moderna’s mResvia vaccine in clinical trials, but a similar safety signal cannot be ruled out from the clinical trial data alone. […] Based on the available data, ACIP and CDC continue to conclude that the benefits of RSV vaccination, in terms of preventable hospitalizations and deaths, outweigh the potential risk for GBS, among adults ages 75 years and older and among adults ages 60-74 years at increased risk of severe RSV disease.

• #59 Early Safety Findings Among Persons Aged ≥60 Years Who Received a Respiratory Syncytial Virus Vaccine — United States, May 3, 2023–April 14, 2024

  https://pmc.ncbi.nlm.nih.gov/articles/PMC11152365/

  Estimated VAERS GBS reporting rates after RSV vaccination were 4.4 and 1.8 reports per million administered doses of Pfizer and GSK vaccines, respectively. […] The findings in this report are generally consistent with those from safety data collected in prelicensure clinical trials, including the observance of GBS cases. […] Expected vaccination reactions (e.g., pain in extremity, headache, and fatigue) were among the most frequently reported events among nonserious VAERS reports.

• #60 Vaccines for Older Adults | RSV | CDC

  https://www.cdc.gov/rsv/vaccines/older-adults.html

  While there is still uncertainty in the amount of increased GBS risk with these vaccines, ACIP understands that the GBS risk appears comparable to, and potentially greater than, that of other currently licensed and recommended adult vaccines. […] There were no reports of GBS among adults who received Moderna’s mResvia vaccine in clinical trials, but a similar safety signal cannot be ruled out from the clinical trial data alone. […] Based on the available data, ACIP and CDC continue to conclude that the benefits of RSV vaccination, in terms of preventable hospitalizations and deaths, outweigh the potential risk for GBS, among adults ages 75 years and older and among adults ages 60-74 years at increased risk of severe RSV disease.

• #61 RSV vaccines: Questions patients may have and how to answer | American Medical Association

  https://www.ama-assn.org/delivering-care/public-health/rsv-vaccines-questions-patients-may-have-and-how-answer

  RSV generally causes mild upper respiratory disease in healthy adults. But for adults 60 or older with certain underlying conditions or other risk factors, RSV can cause serious illness. […] Some of the common side effects include fatigue, fever, headache, muscle or joint pain, nausea and diarrhea. The side effects are typically mild, says the CDC. […] A small number of participants in clinical trials developed serious neurologic conditions, including Guillain-Barr syndrome (GBS), after receiving GSK’s Arexvy or Pfizer’s Abrysvo. Available data support existence of an increased risk of GBS after RSV vaccination with both GSKs Arexvy and Pfizers Abrysvo. […] However, there is still uncertainty in the amount of increased GBS risk with these vaccines. While there were no reports of GBS among adults who received Moderna’s mResvia vaccine in clinical trials, a similar safety signal cannot be ruled out.

• #62 RSV (Respiratory Syncytial Virus) Vaccine: What You Need to Know – Advanced OB-GYN – Syracuse, NY – Auburn and Central New York| Dr. Myron Luthringer | da Vinci Hysterectomy | da Vinci Myomectomy | da Vinci Sacrocolpopexy | Minimally Invasive Robotic Surg

  https://www.advancedob-gyn.com/health-library/hw-view.php?DOCHWID=cdc37

  Pain, redness, and swelling where the shot is given, fatigue (feeling tired), fever, headache, nausea, diarrhea, and muscle or joint pain can happen after RSV vaccination. […] Serious neurologic conditions, including Guillain-Barré syndrome (GBS), have been reported after RSV vaccination in some older adults. At this time, an increased risk of GBS following RSV vaccine among persons aged 60 years and older cannot be confirmed or ruled out. […] Preterm birth and high blood pressure during pregnancy, including pre-eclampsia, have been reported among pregnant women who received RSV vaccine. It is unclear whether these events were caused by the vaccine. […] As with any medicine, there is a very remote chance of a vaccine causing a severe allergic reaction, other serious injury, or death.

• #63 Respiratory Syncytial Virus (RSV) Vaccine Safety | Vaccine Safety | CDC

  https://www.cdc.gov/vaccine-safety/vaccines/rsv.html

  Among adults ages 60 years and older receiving GSK (Arexvy) and Pfizer (Abrysvo) RSV vaccines, a small number of people developed serious neurologic conditions (conditions related to the brain, spinal cord and nerves throughout the body), such as Guillain-Barr syndrome (GBS), within 42 days after vaccination. […] No safety concerns were observed during the clinical trials for infants and young children who received the nirsevimab passive immunization. […] In February 2024, FDA updated the nirsevimab package insert to share that cases of serious hypersensitivity reactions (e.g., hives, fast breathing) have been reported post-licensure. […] Clinical trials identified an increase in the number of preterm births (births occurring before the infant has fully developed in the mother’s womb) among pregnant women who received the vaccine. […] A non-statistically significant increase in hypertensive disorders of pregnancy was also observed during 24 through 36 weeks’ gestation.

• #64 RSV (Respiratory Syncytial Virus) Vaccine: What You Need to Know – Advanced OB-GYN – Syracuse, NY – Auburn and Central New York| Dr. Myron Luthringer | da Vinci Hysterectomy | da Vinci Myomectomy | da Vinci Sacrocolpopexy | Minimally Invasive Robotic Surg

  https://www.advancedob-gyn.com/health-library/hw-view.php?DOCHWID=cdc37

  Pain, redness, and swelling where the shot is given, fatigue (feeling tired), fever, headache, nausea, diarrhea, and muscle or joint pain can happen after RSV vaccination. […] Serious neurologic conditions, including Guillain-Barré syndrome (GBS), have been reported after RSV vaccination in some older adults. At this time, an increased risk of GBS following RSV vaccine among persons aged 60 years and older cannot be confirmed or ruled out. […] Preterm birth and high blood pressure during pregnancy, including pre-eclampsia, have been reported among pregnant women who received RSV vaccine. It is unclear whether these events were caused by the vaccine. […] As with any medicine, there is a very remote chance of a vaccine causing a severe allergic reaction, other serious injury, or death.

• #65 Vaccines for Older Adults | RSV | CDC

  https://www.cdc.gov/rsv/vaccines/older-adults.html

  While there is still uncertainty in the amount of increased GBS risk with these vaccines, ACIP understands that the GBS risk appears comparable to, and potentially greater than, that of other currently licensed and recommended adult vaccines. […] There were no reports of GBS among adults who received Moderna’s mResvia vaccine in clinical trials, but a similar safety signal cannot be ruled out from the clinical trial data alone. […] Based on the available data, ACIP and CDC continue to conclude that the benefits of RSV vaccination, in terms of preventable hospitalizations and deaths, outweigh the potential risk for GBS, among adults ages 75 years and older and among adults ages 60-74 years at increased risk of severe RSV disease.

• #66 RSV Vaccine Recommended for Older Adults Despite Guillain-Barré Syndrome Concerns

  https://www.infectiousdiseaseadvisor.com/news/rsv-vaccination-recommended-for-older-adults-despite-guillain-barre-concerns/

  Symptoms considered possibly related to RSV vaccination were reported by 6328 (39.0%) patients within the first week following vaccination. […] The most frequently reported symptoms following RSV vaccination were pain at or near the injection site (31%), fatigue or tiredness (20.5%), and muscle or body aches (17.5%). […] Other symptoms reported among the study population included sore throat (0.3%), dizziness (0.2%), and runny nose (0.2%). […] The most common AEs included pain in an extremity (13.2%), headache (12.9%), pain (12.8%), injection site pain (12.7%), and fatigue (12.2%). […] Among 28 reports of Guillain-Barr syndrome, 11 occurred following receipt of the Axrevy vaccine and 17 occurred following receipt of the Abrysvo vaccine.

• #67 Side Effects of RSV Vaccines: What’s Normal, What’s Not

  https://www.aarp.org/health/conditions-treatments/info-2024/rsv-vaccine-side-effects.html

  RSV typically causes cold-like symptoms, but in some cases, those symptoms can progress to a lung infection or pneumonia. RSV can worsen other health conditions such as asthma or chronic obstructive pulmonary disease (COPD). […] GBS was flagged as a rare side effect in the clinical trials testing the RSV vaccines. […] The latest data does not change recommendations, because the risk of RSV serious infection in these highly vulnerable populations is vastly greater than is the risk of Guillain-Barr, Schaffner says.

• #68 RSV vaccine for adults | NHS inform

  https://www.nhsinform.scot/healthy-living/immunisation/vaccines/rsv-vaccine-for-adults/

  The RSV vaccine helps protect you by reducing your chances of getting an RSV infection. […] The RSV vaccine helps build up your immunity to the virus. This means your body will fight off the infection more easily. […] Like all medicines, no vaccine is completely effective. Theres still a chance you might get RSV after having the vaccine. However, its likely to be milder and not last as long. […] After having the vaccine you may have some side effects. These are usually mild and disappear within a few days. […] Around the injection site you might experience: pain, redness, swelling. […] Other side effects are rare. In the first season of use in the US, over 12 million doses of RSV vaccine were given. A rare nervous system condition that leads to weakness, known as Guillain-Barr syndrome, was reported in around 10 cases for every million doses of vaccine given. The same condition also occurs after a number of common infections and, rarely, after some other vaccines. […] Overall, it is safer for you to receive the vaccine than to risk having a potentially serious RSV infection.

• #69 RSV vaccine for adults | NHS inform

  https://www.nhsinform.scot/healthy-living/immunisation/vaccines/rsv-vaccine-for-adults/

  The RSV vaccine helps protect you by reducing your chances of getting an RSV infection. […] The RSV vaccine helps build up your immunity to the virus. This means your body will fight off the infection more easily. […] Like all medicines, no vaccine is completely effective. Theres still a chance you might get RSV after having the vaccine. However, its likely to be milder and not last as long. […] After having the vaccine you may have some side effects. These are usually mild and disappear within a few days. […] Around the injection site you might experience: pain, redness, swelling. […] Other side effects are rare. In the first season of use in the US, over 12 million doses of RSV vaccine were given. A rare nervous system condition that leads to weakness, known as Guillain-Barr syndrome, was reported in around 10 cases for every million doses of vaccine given. The same condition also occurs after a number of common infections and, rarely, after some other vaccines. […] Overall, it is safer for you to receive the vaccine than to risk having a potentially serious RSV infection.

• #70 Frequently Asked Questions

  https://www.nhsborders.scot.nhs.uk/patients-and-visitors/respiratory-syncytial-virus-(rsv)/frequently-asked-questions/

  RSV, also known as Respiratory Syncytial Virus, is a common respiratory illness affecting the airways and lungs. RSV can make you wheezy and short of breath but can also lead to more serious illnesses such as pneumonia and other life-threatening conditions. […] It is possible to catch RSV after having the vaccine, but symptoms are likely to be mild and not last as long. It can take a few days for your body to build up extra protection from the vaccination. […] You might have some side effects after having the vaccine, these are usually mild and disappear within a few days. This shows the vaccine is working and teaching your bodys immune system how to protect itself from the RSV virus. Side effects might include pain, swelling or redness at the site of injection, headache, feeling sick, tiredness. These can usually be managed by taking paracetamol and drinking fluids. A member of staff will discuss this with you at your appointment. Other side effects are rare.

• #71 Reddit – The heart of the internet

  https://www.reddit.com/r/PregnancyUK/comments/1fab6cx/rsv_vaccine_and_delayed_side_effects/

  Well today… I have to say that isn’t true! I had my vaccine on Weds 4th Sept, and had no side effects up until this morning (2 days later). The site of the jab is now lightly raised, pink and inflamed, and I have very minor muscular pain around the site if I move my arm up. […] If anyone else has had any delayed side effects from the RSV I’d be very interested to know!

• #72 RSV (Respiratory Syncytial Virus) Vaccine: MedlinePlus Drug InformationLock

  https://medlineplus.gov/druginfo/meds/a623035.html

  RSV vaccine can prevent disease caused by infection with Respiratory Syncytial Virus (RSV). […] Mild symptoms of RSV disease typically resolve in a week or two and include the following: runny nose, decrease in appetite, coughing, sneezing, fever, wheezing. […] In individuals at high risk of serious disease as previously described, RSV may cause shortness of breath and low oxygen levels or may also worsen chronic heart or lung disease, leading to a hospital stay and even potentially death. […] Side effects that have been reported with RSV vaccine include: Redness, swelling, pain, or tenderness where the shot is given, fever, feeling tired, headache, nausea, diarrhea, muscle or joint pain. […] Serious neurologic reactions, including Guillan-Barre Syndrome (GBS), have been reported very rarely after RSV vaccine in clinical trials. […] An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital.

• #73 Respiratory syncytial virus vaccine (intramuscular route) – Mayo Clinic

  https://www.mayoclinic.org/drugs-supplements/respiratory-syncytial-virus-vaccine-intramuscular-route/description/drg-20551166

  Respiratory syncytial virus vaccine is an active immunizing agent used to prevent lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in adults 60 years of age and older. […] This vaccine may cause serious allergic reactions, including anaphylaxis, which can be life-threatening and require immediate medical attention. Tell your doctor right away if you have a rash, itching, a fast heartbeat, trouble breathing, trouble swallowing, or any swelling of your hands, face, or mouth after receiving the vaccine. […] Fainting may occur after you receive this vaccine. You may need to stay for observation after you get the injection to prevent or manage fainting. […] Be sure to notify your doctor of any side effects (eg, feeling faint) that occur after you receive this vaccine. […] Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

• #74 RSV Vaccine Guidance for Older Adults | RSV | CDC

  https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/older-adults.html

  CDC recommends a single dose of RSV vaccine for older adults to help prevent serious RSV infection and hospitalization. […] The RSV vaccine is not currently an annual vaccine, meaning eligible adults do not need to get a dose every RSV season. […] Adverse events after RSV vaccination should be reported to the Vaccine Adverse Event Reporting System (VAERS), even if it is not clear that the vaccine caused the adverse event. […] Coadministration of RSV vaccine with one or more adult vaccines during the same visit may increase common side effects (e.g., pain at the injection site, fever, headache, myalgia). […] Data on immunogenicity of RSV vaccines and other vaccines when coadministered are currently limited. These limited data show coadministration of RSV with other respiratory virus vaccines may result in lower antibody titers, but the clinical significance of this is unknown.

• #75 RSV Immunization Guidance for Infants and Young Children | RSV | CDC

  https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/infants-young-children.html

  Side effects are usually mild, such as pain, redness, or swelling where the injection was given, and resolve quickly. Hypersensitivity reactions are uncommon but have been reported with nirsevimab and similar antibody products. […] Nirsevimab is a monoclonal antibody recommended to children for the prevention of severe RSV disease. It is not a vaccine. RSV vaccines (GSK’s AREXVY, Pfizer’s ABRYSVO, and Moderna’s mResvia) have been approved for adults but are NOT approved for use in infants or young children. […] Adverse reactions might occur after administration of nirsevimab alone; these reactions may be reported to MedWatch online, by fax, by mail, or by contacting FDA at 1-800-FDA-1088. Adverse reactions might occur after the coadministration of nirsevimab with a vaccine; these reactions should be reported to the Vaccine Adverse Event Reporting System (VAERS), and reports should specify that the patient received nirsevimab on the VAERS form in Section 9: „Prescriptions, over-the-counter medications, dietary supplements, or herbal remedies being taken at the time of vaccination.”

• #76 LAC | DPH – Vaccine Preventable Disease Control Program

  http://ph.lacounty.gov/ip/diseases/RSV/index.htm

  RSV vaccine can be given at the same time as other vaccines. […] Side effects from RSV vaccine are usually mild. Common side effects may include: Redness, swelling, and pain at the site of injection, Fatigue, Fever, Headache, Nausea, Diarrhea, Muscle or joint pain. […] RSV immunization effectiveness varies depending on vaccine given, previous doses, age, time, and medical history. In older adults, the RSV vaccines are at least 73-83 % effective in preventing RSV-associated emergency visits and hospitalizations in adults ages 60 years and older. In pregnant people, the maternal RSV vaccine is at least 68% effective in preventing RSV-associated hospitalizations in babies. In infants and young children, nirsevimab (Beyfortus) is at least 80-90% effective in preventing RSV-associated hospitalizations in babies.

• #77 Respiratory Syncytial Virus (RSV) | Patients & Visitors | DHMC and Clinics

  https://www.dartmouth-hitchcock.org/patients-visitors/rsv

  The RSV vaccine is not currently an annual vaccine. If you received the vaccine last year, you dont need to get it again this year. […] It is ok to get the RSV vaccine at the same time as the COVID and flu vaccines, but it might raise the chances of having side effects.

• #78 RSV Vaccine Guidance for Older Adults | RSV | CDC

  https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/older-adults.html

  CDC recommends a single dose of RSV vaccine for older adults to help prevent serious RSV infection and hospitalization. […] The RSV vaccine is not currently an annual vaccine, meaning eligible adults do not need to get a dose every RSV season. […] Adverse events after RSV vaccination should be reported to the Vaccine Adverse Event Reporting System (VAERS), even if it is not clear that the vaccine caused the adverse event. […] Coadministration of RSV vaccine with one or more adult vaccines during the same visit may increase common side effects (e.g., pain at the injection site, fever, headache, myalgia). […] Data on immunogenicity of RSV vaccines and other vaccines when coadministered are currently limited. These limited data show coadministration of RSV with other respiratory virus vaccines may result in lower antibody titers, but the clinical significance of this is unknown.

• #79 Health Care Provider Fact Sheet: Addressing Common Concerns About Flu, COVID-19, and RSV Vaccines | HHS.govLock

  https://www.hhs.gov/risk-less-do-more/for-health-care-providers/fact-sheet-addressing-common-concerns-flu-covid-19-and-rsv-vaccines/index.html

  RSV vaccines were proven to work well to protect people from getting really sick from RSV in clinical trials. The most common side effects are a sore arm, lack of energy, and headache, and those symptoms don’t last long. Severe allergic reactions are rare. […] The RSV vaccine helps protect you from serious symptoms. […] You may have more side effects if you get more than one of these vaccines at the same time, but symptoms will likely be mild and should not last long. Some of the most common side effects are arm pain or swelling, headache, and fatigue.

• #80 RSV Vaccine Guidance for Older Adults | RSV | CDC

  https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/older-adults.html

  CDC recommends a single dose of RSV vaccine for older adults to help prevent serious RSV infection and hospitalization. […] The RSV vaccine is not currently an annual vaccine, meaning eligible adults do not need to get a dose every RSV season. […] Adverse events after RSV vaccination should be reported to the Vaccine Adverse Event Reporting System (VAERS), even if it is not clear that the vaccine caused the adverse event. […] Coadministration of RSV vaccine with one or more adult vaccines during the same visit may increase common side effects (e.g., pain at the injection site, fever, headache, myalgia). […] Data on immunogenicity of RSV vaccines and other vaccines when coadministered are currently limited. These limited data show coadministration of RSV with other respiratory virus vaccines may result in lower antibody titers, but the clinical significance of this is unknown.

• #81 RSV (Respiratory Syncytial Virus) Preventive Antibody Immunization Information Statement | CDC

  https://www.cdc.gov/vaccines/vpd/rsv/immunization-information-statement.html

  A respiratory syncytial virus (RSV) preventive antibody can prevent severe lung disease caused by RSV. […] Symptoms of RSV infection may include runny nose, decrease in appetite, coughing, sneezing, fever, or wheezing. […] RSV preventive antibodies can be given at the same time as vaccines routinely recommended for infants and young children. […] After getting an RSV preventive antibody, your child might have temporary pain, redness, swelling where the injection was given, or a rash. […] As with any medicine, there is a very remote chance that RSV Immunization could cause a severe allergic reaction, other serious injury, or death. […] An allergic reaction could occur after your child leaves the hospital or clinic. If you see signs of a severe allergic reaction (for example, hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get your child to the nearest hospital. […] Call your health care provider if you see any other symptoms that concern you.

• #82 Vaccines for Older Adults | RSV | CDC

  https://www.cdc.gov/rsv/vaccines/older-adults.html

  CDC recommends everyone ages 75 and older get an RSV vaccine. […] CDC recommends adults ages 60-74 who are at increased risk of severe RSV disease get an RSV vaccine. […] The RSV vaccine is not currently an annual vaccine. […] Side effects such as pain, redness, and swelling where the shot is given, fatigue, fever, headache, nausea, diarrhea, and muscle or joint pain may occur after you get an RSV vaccine. […] A small number of participants in clinical trials developed serious neurologic conditions, including Guillain-Barr syndrome (GBS), after receiving GSK’s Arexvy or Pfizer’s Abrysvo. […] The Advisory Committee on Immunization Practices (ACIP) concluded that the available data support existence of an increased risk of GBS after RSV vaccination with both GSK’s Arexvy and Pfizer’s Abrysvo.

• #83 RSV Vaccine Guidance for Older Adults | RSV | CDC

  https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/older-adults.html

  CDC recommends a single dose of RSV vaccine for older adults to help prevent serious RSV infection and hospitalization. […] The RSV vaccine is not currently an annual vaccine, meaning eligible adults do not need to get a dose every RSV season. […] Adverse events after RSV vaccination should be reported to the Vaccine Adverse Event Reporting System (VAERS), even if it is not clear that the vaccine caused the adverse event. […] Coadministration of RSV vaccine with one or more adult vaccines during the same visit may increase common side effects (e.g., pain at the injection site, fever, headache, myalgia). […] Data on immunogenicity of RSV vaccines and other vaccines when coadministered are currently limited. These limited data show coadministration of RSV with other respiratory virus vaccines may result in lower antibody titers, but the clinical significance of this is unknown.

• #84 Respiratory syncytial virus (RSV) | The Australian Immunisation Handbook

  https://immunisationhandbook.health.gov.au/contents/vaccine-preventable-diseases/respiratory-syncytial-virus-rsv

  RSV (respiratory syncytial virus) is a virus that causes upper and lower respiratory tract infection. RSV infection can cause severe disease, particularly in very young and older people. […] RSV vaccination is recommended for pregnant women to protect their newborn infant. […] A single dose of RSV vaccine is recommended to protect older people. […] The medical risk factors for severe RSV disease include preterm birth (gestational age <32 weeks) for infants and young children, cardiac disease, chronic respiratory conditions, immunocompromising conditions, chronic metabolic disorders, chronic kidney disease (stage 4 or 5), chronic neurological conditions, and obesity. [...] RSV infection is associated with substantial disease burden and is a leading cause of lower respiratory tract disease hospitalisation in infants aged <12 months.

• #85 RSV Symptoms, Treatment & Vaccines | University Hospitals | University Hospitals

  https://www.uhhospitals.org/services/rsv-treatment-services

  Most healthy adults with RSV experience only mild symptoms that don’t require medical treatment or hospitalization. However, certain individuals are at a higher risk of developing severe RSV. According to the CDC’s estimate, RSV causes up to 160,000 hospitalizations and up to 10,000 deaths annually among adults ages 65 and older. Risk factors include: Age: Adults ages 75 and older are at an increased risk of severe RSV. Chronic conditions: This includes adults with chronic heart or lung disease. Weakened immune system: Certain medical conditions or medications can weaken the immune system and put individuals at an increased risk of severe RSV. Underlying medical conditions: These can include conditions such as diabetes or obesity. Living in nursing homes: RSV and other illnesses can spread rapidly in group living facilities like nursing homes, and the elderly and medically frail are more susceptible to severe illness.

• #86 Respiratory syncytial virus (RSV) – Symptoms & causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/respiratory-syncytial-virus/symptoms-causes/syc-20353098

  The FDA approved an RSV vaccine called Abrysvo for pregnant people to prevent RSV in infants from birth through 6 months of age. A single-dose shot of Abrysvo can be given sometime from 32 weeks through 36 weeks of pregnancy during September through January in the U.S. […] To help prevent RSV infection, the FDA approved RSV vaccines for adults age 60 and older. […] The CDC recommends that adults age 60 and older talk with their healthcare professional about getting an RSV vaccine, especially if they’re at higher risk of getting severe RSV. Two vaccines are available for this age group: Abrysvo and Arexvy. The CDC does not recommend one over the other. Each is a single-dose shot.

• #87 Respiratory Syncytial Virus (RSV)

  https://www.nj.gov/health/respiratory-viruses/rsv/

  Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms such as coughing, sneezing, wheezing, fever, runny nose, and decrease in appetite. […] Infants/young children and older adults are most at risk for severe disease that may require hospitalization. RSV can also cause severe symptoms in people with weakened immune systems or chronic heart and lung diseases. […] People infected with RSV usually show symptoms within four to six days after getting infected. Symptoms usually appear in stages and not all at once. […] In very young infants with RSV, the only symptoms may be irritability, decreased activity, and breathing difficulties. […] There are two ways to protect your baby from getting very sick from RSV. One is an RSV vaccine given during pregnancy. The other is an RSV antibody product that provides antibodies to your baby after birth.

• #88 Respiratory Syncytial Virus (RSV)

  https://www.nj.gov/health/respiratory-viruses/rsv/

  Getting the RSV vaccine, Abrysvo, if you are 32-36 weeks pregnant during RSV season to maximize protection for babies after birth. This vaccine has been shown to greatly reduce the risk of hospitalization for babies in the first six months after birth. […] There is no specific treatment for illnesses caused by RSV. Most people will recover on their own. […] If you are concerned about your symptoms, contact your health care provider. […] To prevent severe RSV disease in infants, the CDC recommends either maternal RSV vaccination or infant immunization with RSV monoclonal antibodies. Most infants will not need both. […] One dose of maternal RSV vaccine during weeks 32 through 36 of pregnancy, administered immediately before or during RSV season (typically fall through spring). Abrysvo is the only RSV vaccine recommended during pregnancy. […] One dose of nirsevimab for all infants younger than 8 months born during or entering their first RSV season. […] One dose of nirsevimab for infants and children aged 8-19 months who are at increased risk for severe RSV disease and entering their second RSV season.

• #89 Respiratory syncytial virus (RSV) vaccine | HealthLink BC

  https://immunizebc.ca/vaccines/respiratory-syncytial-virus-rsv

  These medications provide immediate but temporary protection. Nirsevimab can protect infants for up to 5 months after it is provided. […] The purpose of the vaccine during pregnancy is to protect the baby after birth. When a pregnant person receives the vaccine, their body produces antibodies that pass through the placenta to the baby, providing passive immunity. This gives the baby early protection against RSV during the first few months of life, when they are most vulnerable. […] ABRYSVO is an inactivated (non-live) vaccine that is safe for pregnant people and their developing babies. It is the only vaccine approved for use in pregnancy that has been intentionally tested in pregnant people during clinical trials. Other RSV vaccines are not approved for use in pregnancy.

• #90 Respiratory Syncytial Virus (RSV)

  https://www.nj.gov/health/respiratory-viruses/rsv/

  Getting the RSV vaccine, Abrysvo, if you are 32-36 weeks pregnant during RSV season to maximize protection for babies after birth. This vaccine has been shown to greatly reduce the risk of hospitalization for babies in the first six months after birth. […] There is no specific treatment for illnesses caused by RSV. Most people will recover on their own. […] If you are concerned about your symptoms, contact your health care provider. […] To prevent severe RSV disease in infants, the CDC recommends either maternal RSV vaccination or infant immunization with RSV monoclonal antibodies. Most infants will not need both. […] One dose of maternal RSV vaccine during weeks 32 through 36 of pregnancy, administered immediately before or during RSV season (typically fall through spring). Abrysvo is the only RSV vaccine recommended during pregnancy. […] One dose of nirsevimab for all infants younger than 8 months born during or entering their first RSV season. […] One dose of nirsevimab for infants and children aged 8-19 months who are at increased risk for severe RSV disease and entering their second RSV season.

• #91 Vaccines for Older Adults | RSV | CDC

  https://www.cdc.gov/rsv/vaccines/older-adults.html

  While there is still uncertainty in the amount of increased GBS risk with these vaccines, ACIP understands that the GBS risk appears comparable to, and potentially greater than, that of other currently licensed and recommended adult vaccines. […] There were no reports of GBS among adults who received Moderna’s mResvia vaccine in clinical trials, but a similar safety signal cannot be ruled out from the clinical trial data alone. […] Based on the available data, ACIP and CDC continue to conclude that the benefits of RSV vaccination, in terms of preventable hospitalizations and deaths, outweigh the potential risk for GBS, among adults ages 75 years and older and among adults ages 60-74 years at increased risk of severe RSV disease.

• #92 Learn More: What You Need to Know about RSV Vaccines for Older Adults (60+) | HealthInAging.org

  https://www.healthinaging.org/tools-and-tips/learn-more-what-you-need-know-about-rsv-vaccines-older-adults-60

  Respiratory syncytial virus, or RSV, is a virus that causes infections of the lungs and breathing passages. It is highly contagious (easy to get from other people). In older adults, RSV is a common cause of a lung disease which can cause life-threatening pneumonia. The RSV vaccine can help older adults at risk of RSV. […] The RSV vaccine has both harms and benefits. […] Potential harms of getting an RSV shot include: A small number of people experienced serious inflammatory neurological events after receiving the vaccine. However, the majority of people who have received the RSV vaccine did not experience those harms. […] If you get the RSV vaccine, some possible side effects include: Pain, redness, or swelling in the location where you received the shot; Tiredness, aches in your body or joints, fever, nausea, or diarrhea after receiving the shot; Most people who get an RSV shot do not have any serious problems with it. Most side effects are mild and usually go away within a few days.

• #93 Respiratory Syncytial Virus (RSV) | Patients & Visitors | DHMC and Clinics

  https://www.dartmouth-hitchcock.org/patients-visitors/rsv

  The RSV vaccine is not currently an annual vaccine. If you received the vaccine last year, you dont need to get it again this year. […] It is ok to get the RSV vaccine at the same time as the COVID and flu vaccines, but it might raise the chances of having side effects.

• #94 The RSV Vaccine for Cancer Patients: What You Need to Know

  https://blog.dana-farber.org/insight/2025/01/the-rsv-vaccine-for-cancer-patients-what-you-need-to-know/

  RSV symptoms are similar to the common cold congestion, runny nose, fever, and sore throat. […] RSV infection is usually mild, but it can be severe for infants, older adults, and individuals with immunocompromising conditions, including cancer. […] The RSV vaccine is safe for people with cancer. Vaccinations are an essential part of care for people with cancer because they often have weakened immune systems and therefore are more likely to be at risk of severe infections from viruses like RSV. […] It is not yet clear how long immunity lasts, though according to the CDC, protection does last longer than a year.

• #95 Respiratory Syncytial Virus (RSV) Vaccine Safety | Vaccine Safety | CDC

  https://www.cdc.gov/vaccine-safety/vaccines/rsv.html

  RSV immunizations may be given at the same time as other routine immunizations for older adults, pregnant women, young children, and infants to protect against severe RSV. […] Most common side effects reported after RSV immunization are usually mild or moderate. […] Pain where the shot is given […] Fatigue (feeling tired) […] Headache […] Muscle pain […] Nausea […] Pain, redness, hardness, or swelling where shot is given […] Rash […] Severe allergic reactions following vaccination are rare but can be life threatening. If someone has symptoms of a severe allergic reaction which can include hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, and weakness call 911 immediately. […] In clinical trials assessing the safety of RSV vaccines in adults ages 60 years and older, the frequency of serious adverse events (SAEs) was similar in the vaccinated group compared to the placebo (control, or unvaccinated) group.

Zobacz więcej